276 related articles for article (PubMed ID: 21956219)
1. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
[TBL] [Abstract][Full Text] [Related]
2. A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.
El-Hoss J; Cheng T; Carpenter EC; Sullivan K; Deo N; Mikulec K; Little DG; Schindeler A
J Bone Joint Surg Am; 2014 Jul; 96(14):e117. PubMed ID: 25031379
[TBL] [Abstract][Full Text] [Related]
3. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.
Ghadakzadeh S; Kannu P; Whetstone H; Howard A; Alman BA
FASEB J; 2016 Sep; 30(9):3227-37. PubMed ID: 27306335
[TBL] [Abstract][Full Text] [Related]
5. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
6. JNK inhibitors increase osteogenesis in Nf1-deficient cells.
Sullivan K; El-Hoss J; Little DG; Schindeler A
Bone; 2011 Dec; 49(6):1311-6. PubMed ID: 21964323
[TBL] [Abstract][Full Text] [Related]
7. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
8. Models of tibial fracture healing in normal and Nf1-deficient mice.
Schindeler A; Morse A; Harry L; Godfrey C; Mikulec K; McDonald M; Gasser JA; Little DG
J Orthop Res; 2008 Aug; 26(8):1053-60. PubMed ID: 18383150
[TBL] [Abstract][Full Text] [Related]
9. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
10. Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I.
Lee DY; Cho TJ; Lee HR; Lee K; Moon HJ; Park MS; Yoo WJ; Chung CY; Choi IH
Clin Orthop Surg; 2011 Sep; 3(3):230-7. PubMed ID: 21909471
[TBL] [Abstract][Full Text] [Related]
11. Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.
Schindeler A; Birke O; Yu NY; Morse A; Ruys A; Baldock PA; Little DG
J Bone Joint Surg Br; 2011 Aug; 93(8):1134-9. PubMed ID: 21768643
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
Baht GS; Nadesan P; Silkstone D; Alman BA
Bone; 2017 May; 98():31-36. PubMed ID: 28254468
[TBL] [Abstract][Full Text] [Related]
13. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
[TBL] [Abstract][Full Text] [Related]
14. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
15. Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1.
Cho TJ; Seo JB; Lee HR; Yoo WJ; Chung CY; Choi IH
J Bone Joint Surg Am; 2008 Dec; 90(12):2735-44. PubMed ID: 19047720
[TBL] [Abstract][Full Text] [Related]
16. Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing.
Kawakatsu M; Kanno S; Gui T; Gai Z; Itoh S; Tanishima H; Oikawa K; Muragaki Y
Exp Mol Pathol; 2011 Feb; 90(1):107-15. PubMed ID: 21035443
[TBL] [Abstract][Full Text] [Related]
17. Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene.
Sakamoto A; Yoshida T; Yamamoto H; Oda Y; Tsuneyoshi M; Iwamoto Y
J Orthop Sci; 2007 Jul; 12(4):361-5. PubMed ID: 17657556
[TBL] [Abstract][Full Text] [Related]
18. Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.
Wang W; Nyman JS; Moss HE; Gutierrez G; Mundy GR; Yang X; Elefteriou F
J Bone Miner Res; 2010 Jul; 25(7):1658-67. PubMed ID: 20200958
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.
Wang T; Wang Y; Menendez A; Fong C; Babey M; Tahimic CG; Cheng Z; Li A; Chang W; Bikle DD
J Bone Miner Res; 2015 Sep; 30(9):1572-84. PubMed ID: 25801198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
